Synchrony Financial (SYF) stock saw a modest uptick, ending the day at $68.11 which represents a slight increase of $2.05 or 3.10% from the prior close of $66.06. The stock opened at $67.03 and touched a low of $67.

Synchrony Financial (NYSE:SYF – Get Free Report) was upgraded by Barclays from an “equal weight” rating to an “overweight” rating in a report released on Monday,Briefing.com Automated Import reports.

Barclays analyst Terry Ma upgraded Synchrony Financial (SYF – Research Report) to a Buy today and set a price target of $79.00. The company’s

Fintel reports that on January 6, 2025, Barclays upgraded their outlook for Synchrony Financial - Preferred Stock (NYSE:SYF.PRB) from Equal-Weight to Overweight. There are 42 funds or institutions ...

The six-year-long Apple Card partnership between Goldman Sachs and Apple might end sooner than expected. Here's who could take the business.

It's been Goldman Sachs in the background since the Apple Card's launch in 2019. Ever since its introduction in 2019, the Apple Card has been powered

APPLE is in talks with Barclays to replace Goldman Sachs as the tech giant’s credit card partner, said two sources familiar with the matter, as the Wall Street giant steps back from its consumer finance ambitions.

Several financial firms are vying to replace Goldman, which launched the credit card with Apple in 2019, the sources said. While other lenders are tempted by working with Apple, one of the world's most recognizable brands,

The Apple Card, which has now been available in the USA for over five years, needs a new bank. Now there are other candidates.

Apple is in talks with two major financial firms, as it looks for a new Apple Card partner to replace Goldman Sachs.

Medical credit cards are increasingly pushed on patients across America as the costs of health, dental, and veterinary procedures rise. CareCredit had 12 million cardholders and 270,000 participating providers in 2024,